comprehensive -WSS

comprehensive

author：knowledge 2025-09-27 19:37:20 - browse：62327

Matts Take Column Illustration — Molly Ferguson for STAT

The news that the weight loss drug Wegovy reduced the risk of heart attacks and strokes in overweight volunteers opens up the door to vastly expanded use of the drug and medicines like it, known as GLP-1 medicines.

That could have a big, positive impact on public health, and it will very likely swell the coffers of the pharmaceutical companies that make these medicines, including Wegovy’s maker, Novo Nordisk, and Eli Lilly, now the most valuable drug company in history thanks largely to hopes for its GLP-1, Mounjaro. These are medicines that could save lives, make money, and perhaps reshape our culture. But they are also, we are learning, not without risk.

So what’s next?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Readout LOUD: Venture capital, Gilead, and more M&A

WSS

Bernie brings in new pharma CEOs to talk drug prices

Why Novartis is going to walk from its acquisition of MorphoSys

Medicare Advantage plans can’t deny care with AI, CMS warns

Cano Health’s bankruptcy is a warning for Medicare Advantage

Unique patient identifier: Experts argue the benefits, pitfalls

Would Medicare drug price negotiations stall in a shutdown?

knowledge

comprehensive

hotspot

At least 13 dead in Texas as scorching temps continue

How one patient went off dialysis — and others can too

Medicare details structure of new drug price negotiation program

Mindstrong's demise and the future of mental health care

Novavax promises a turnaround & Lilly roils the obesity market

Bernie brings in new pharma CEOs to talk drug prices

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Why do women spend more than men on medical expenses?

focus

Johnson & Johnson sued for allegedly overpaying for workers' drugs

A protest over insulin prices is seen as a fight for life

Readout LOUD: Venture capital, Gilead, and more M&A

Why CTE doesn’t keep Americans from enjoying the Super Bowl

https://cbu01.alicdn.com/img/ibank/2015/862/294/2573492268_830434976.220x220xz.jpg

Gene therapy for Afghan refugees’ infant will be fully covered

hotspot

entertainment

focus

explore